News FocusBIOMEDICAL SCIENCE

Can Money Turn Singapore Into a Biotech Juggernaut?

See allHide authors and affiliations

Science  30 Aug 2002:
Vol. 297, Issue 5586, pp. 1470-1473
DOI: 10.1126/science.297.5586.1470

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

SINGAPORE-- Singapore is betting that a $2 billion initiative will create the talent pool and business climate needed for a world-class biomedical enterprise. The city-state will need to attract enough rank-and-file life science researchers to achieve a critical mass, and then it will need to keep them long enough to have an impact. But the gamble has already started to pay off.

View Full Text

Stay Connected to Science